Shingles vaccine linked to lower risk of heart-related deaths
帶狀皰疹疫苗與降低心臟相關疾病死亡風險有關
A recent breakthrough in medical research suggests that the shingles vaccine, primarily known for preventing a painful skin rash, may offer a surprising bonus: protection for your heart.
一項近期的醫學研究突破顯示，帶狀皰疹疫苗除了眾所周知能預防疼痛的皮疹外，或許還有一項令人驚喜的額外功效：保護心臟。
Studies involving over one million adults have linked the vaccine to a significant decrease in cardiovascular risks.
針對超過一百萬名成年人的研究將此疫苗與心血管風險的顯著下降連結起來。
One major 2026 study found that for patients already living with heart disease, vaccination was associated with a 46% lower risk of major cardiac events.
一項2026年的主要研究發現，對於已經患有心臟病的患者而言，接種疫苗與重大心臟事件風險降低46%相關。
Experts believe the vaccine works by preventing the systemic inflammation that a shingles infection typically triggers.
專家認為，該疫苗的作用機制在於防止帶狀皰疹感染通常會引發的全身性發炎。
This inflammation can damage blood vessels and increase the risk of blood clots, which are common causes of heart attacks.
這種發炎會損害血管並增加血栓風險，而血栓是心臟病發作的常見原因。
Because this protection is significant, some cardiologists are now proposing that vaccines should be considered a 'fourth pillar' of heart disease prevention, alongside managing blood pressure, cholesterol, and diabetes.
由於此種保護作用顯著，一些心臟科醫師目前提議，應將疫苗視為與控制血壓、膽固醇和糖尿病並列的「第四根支柱」，作為預防心臟病的方法。
As health agencies continue to study the long-term effects of modern vaccines like Shingrix, this research highlights that the shingles shot is not just for skin health; it may be a vital tool for protecting your heart for years to come.
隨著衛生機構持續研究Shingrix等現代疫苗的長期影響，這項研究突顯出帶狀皰疹疫苗不僅僅是為了皮膚健康，它或許還能成為未來多年保護心臟的重要工具。
